Literature DB >> 2189009

Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis.

F De Bernardis1, L Agatensi, I K Ross, G W Emerson, R Lorenzini, P A Sullivan, A Cassone.   

Abstract

The presence of the secretory aspartate (acid) proteinase in the vaginal fluid of candidal vaginitis patients and controls was studied by ELISA and immunoblot (Western blot). In addition, a proteinase-deficient mutant strain of Candida albicans (IR24) was compared with the wild-type parent strain (10261) for ability to infect the vagina of pseudoestrus rats under estradiol treatment. Among the 67 women examined, proteinase was detected only in 22 harboring C. albicans (range, 42-233 ng/ml of vaginal fluid), at concentrations significantly higher in the 14 vaginitis patients than in the 8 asymptomatic fungal carriers. Western blots confirmed the presence of only one protein band of approximately 43 kDa, corresponding to that of the purified proteinase, in the ELISA-positive vaginal fluids. Experimental vaginal infection was significantly more extensive and persistent in rats infected with the proteinase-producer strain than in those challenged with the proteinase-deficient mutant, and the enzyme was detected in the vaginas of the former but not of the latter animals. Both strains 10261 and IR24 developed hyphal forms to a roughly similar extent during infection, and both showed a comparable adherence in vitro to vaginal and buccal epithelial cells. The clinical and experimental evidence support a role for secretory proteinase as a virulence factor in the pathogenesis of candidal vaginitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189009     DOI: 10.1093/infdis/161.6.1276

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.

Authors:  D Arzeni; M Del Poeta; O Simonetti; A M Offidani; L Lamura; M Balducci; N Cester; A Giacometti; G Scalise
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

Review 2.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

Review 3.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

4.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

5.  DNA fingerprinting and electrophoretic karyotype of environmental and clinical isolates of Candida parapsilosis.

Authors:  G Carruba; E Pontieri; F De Bernardis; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

6.  Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus.

Authors:  M McCullough; B Ross; P Reade
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 7.  The role of Candida albicans secreted aspartic proteinase in the development of candidoses.

Authors:  L Hoegl; M Ollert; H C Korting
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

8.  Polyene susceptibility is dependent on nitrogen source in the opportunistic pathogen Candida albicans.

Authors:  Brian G Oliver; Peter M Silver; Theodore C White
Journal:  J Antimicrob Chemother       Date:  2008-03-13       Impact factor: 5.790

9.  The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects.

Authors:  F De Bernardis; M Boccanera; L Rainaldi; C E Guerra; I Quinti; A Cassone
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 10.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.